Bayer HealthCare

NEWBURY, England, January 6, 2011 - Bayer has submitted an application for marketing authorisation to the European Medicines Agency (EMA) for the oral anticoagulant rivaroxaban in stroke prevention in patients with non-valvular atrial fibrillation, as well as for the treatment of deep vein thrombosis (DVT) and prevention of recurrent DVT and pulmonary embolism (PE).

MONHEIM, Germany, December 13, 2010 - In a study published online last week in Medical and Veterinary Entomology, international experts reported the latest data on flea susceptibility to imidacloprid, revealing that after more than a decade of widespread use around the world, there is no evidence of resistance to this invaluable treatment.

MONHEIM, Germany, November 15, 2010 - Bayer Animal Health today outlined their vision for the future of cattle production at the 26th World Buiatrics Congress in Santiago, Chile.

MONHEIM, Germany, July 28, 2010 - Fascinating studies giving new insights into the spread of leishmaniosis in the UK and France, the appearance of new CVBDs in Germany, the state of heartworm infection in Korea and the neurological impact on humans of long-term bartonella infection from the USA are among the papers now available for download from www.cvbd.org, as the proceedings of the 5th Annual Canine Vector Borne Disease (CVBD) World Forum are made available online today.

VANCOUVER, July 22, 2010 - Bayer Animal Health today revealed their new commitment to the livestock community at the 21st International Pig Veterinary Society (IPVS) Congress in Vancouver, Canada.